Fund comparison · from official SEC filings

BBH vs TBXU: how much do they overlap?

VanEck Biotech ETF and Direxion Daily Biotech Top 5 Bull 2X ETF
Holdings overlap
38%
of assets, by weight
Shared positions
5
of 25 / 9 holdings
BBH expense ratio
0.35%
net, per year
TBXU expense ratio
0.97%
net, per year
Shared holdings
Company
BBH
TBXU
G
GILDGILEAD SCIENCES INC
14.61%
8.28%
A
AMGNAMGEN INC
14.52%
8.68%
A
ARGXARGENX SE - ADR
5.27%
10.26%
R
REGNREGENERON PHARMACEUTICALS
7.50%
8.69%
V
VRTXVERTEX PHARMACEUTICALS INC
8.05%
8.36%
Only in BBH
I
INSMINSMED INC
4.58%
I
IQVIQVIA HOLDINGS INC
4.29%
A
ALNYALNYLAM PHARMACEUTICALS INC
4.10%
N
NTRANATERA INC
3.97%
U
UTHRUNITED THERAPEUTICS CORP
3.80%
B
BIIBBIOGEN INC
3.72%
O
ONCBEONE MEDICINES LTD-ADR
3.24%
M
MRNAMODERNA INC
3.10%
R
RVMDREVOLUTION MEDICINES INC
2.86%
I
ILMNILLUMINA INC
2.49%
I
INCYINCYTE CORP
2.24%
B
BNTXBIONTECH SE-ADR
2.15%
N
NBIXNEUROCRINE BIOSCIENCES INC
1.93%
B
BMRNBIOMARIN PHARMACEUTICAL INC
1.39%
T
TECHBIO-TECHNE CORP
1.35%
C
CRLCHARLES RIVER LABORATORIES
1.28%
I
ICLRICON PLC
1.27%
Q
QGENQIAGEN N.V.
1.14%
T
TEMTEMPUS AI INC-CL A
0.93%
G
GVMXXSTATE ST INST US GOV MM-PREM
0.23%
Only in TBXU
?
DREYFUS GOVERNMENT CASH MANAGE
30.53%
?
GOLDMAN FINANCIAL
25.97%
?
GOLDMAN SACHS LIQ ES FD A
5.51%
?
N/A
-6.28%
Hold BBH and TBXU together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.
BBH vs TBXU: 38% holdings overlap — Unwrap.Fund